HILLSTREAM BIOPHARMA INC's ticker is and the CUSIP is 432705101. A total of 9 filers reported holding HILLSTREAM BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,813 | -40.1% | 19,067 | +9.4% | 0.00% | – |
| Q2 2023 | $6,361 | +70577.8% | 17,427 | +47.3% | 0.00% | – |
| Q1 2023 | $9 | +125.0% | 11,828 | +30.7% | 0.00% | – |
| Q4 2022 | $4 | -99.9% | 9,050 | +6.1% | 0.00% | – |
| Q3 2022 | $7,000 | +75.0% | 8,531 | +85.3% | 0.00% | – |
| Q2 2022 | $4,000 | -69.2% | 4,605 | -43.2% | 0.00% | – |
| Q1 2022 | $13,000 | – | 8,111 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JANE STREET GROUP, LLC | 11,777 | $10,000 | 0.00% |
| UBS Group AG | 10,735 | $9,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 2,000 | $2,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 30 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 11,220 | $9,000 | 0.00% |
| MORGAN STANLEY | 1 | $0 | 0.00% |
| Citadel Advisors | 44,065 | $36,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 8,531 | $7,000 | 0.00% |